InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Liang Howard, Chief Financial Officer. Officer active across 1 company, notably BeiGene, Ltd.. In total, 4 filings have been recorded. Breakdown: 1 buy · 3 sells. Total volume traded: €458k. History available since 7 June 2021. The latest transaction was disclosed on 28 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Liang Howard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
446 shares@ US$365.0029.8% of flowAmerican Depositary SharesSEC:0001651308-21-000138:0
486 shares@ US$325.891929.0% of flowAmerican Depositary SharesSEC:0001651308-21-000125:0
650 shares@ US$354.157741.2% of flowAmerican Depositary SharesSEC:0001651308-21-000109:0
65,000 sharesOrdinary SharesSEC:0001104659-16-095143:0
Canonical exit: 8 May 2016 (T+90)
4 of 4 declarations
About Liang Howard
Howard Liang is the Chief Financial Officer and Chief Strategy Officer at BeiGene, Ltd. In this role, he is responsible for financial management and strategy of the company, playing a key role in its growth and development.
